Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Compérat

Showing results (191-200 of 243) with videos related to

Pageof 25
Sort By:
Human Pathology|July 16, 2013
Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: the superiority of fluorescence in situ hybridization over ERG immunohistochemistryLindsay A Schelling, Sean R Williamson, Shaobo Zhang, et al.
World Journal of Urology|June 18, 2021
Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancerSatoshi Katayama, Keiichiro Mori, Benjamin Pradere, et al.
World Journal of Urology|May 8, 2026
Pathological assessment of morcellated tissue after ERBT: insights from a two-round Delphi surveyYossi Ventura, Andrey Morozov, Ronald Chan, et al.
The Journal of Urology|November 28, 2015
Oncologic Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma of the Distal UreterThomas Seisen, Laurent Nison, Mezut Remzi, et al.
The Journal of Urology|June 28, 2021
Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical CystectomyVictor M Schuettfort, Benjamin Pradere, David D'Andrea, et al.
European Urology Oncology|May 16, 2024
Clofarabine Has a Superior Therapeutic Window as compared to Gemcitabine in Preclinical Bladder Cancer ModelsMichael Gutmann, Iris E Ertl, Paula Herek, et al.
The American Journal of Surgical Pathology|February 23, 2016
Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma SyndromeKiril Trpkov, Ondrej Hes, Abbas Agaimy, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
EGFR alterations and EML4-ALK rearrangement in primary adenocarcinoma of the urinary bladderRiley E Alexander, Rodolfo Montironi, Antonio Lopez-Beltran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2014
Next-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling genesGabriel G Malouf, Xiaoping Su, Hui Yao, et al.
European Urology Focus|June 10, 2025
A Systematic Review and Meta-analysis on Perioperative Stenting/Dwell Time and Postoperative Outcomes in Patients Undergoing Radical Cystectomy and Urinary Diversion for Bladder CancerMithun Kailavasan, Alberto Martini, Max Bruins, et al.
Pageof 25

Showing results (191-200 of 243) with videos related to

Sort By:
Pageof 25
Human Pathology|July 16, 2013
Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: the superiority of fluorescence in situ hybridization over ERG immunohistochemistryLindsay A Schelling, Sean R Williamson, Shaobo Zhang, et al.
World Journal of Urology|June 18, 2021
Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancerSatoshi Katayama, Keiichiro Mori, Benjamin Pradere, et al.
World Journal of Urology|May 8, 2026
Pathological assessment of morcellated tissue after ERBT: insights from a two-round Delphi surveyYossi Ventura, Andrey Morozov, Ronald Chan, et al.
The Journal of Urology|November 28, 2015
Oncologic Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma of the Distal UreterThomas Seisen, Laurent Nison, Mezut Remzi, et al.
The Journal of Urology|June 28, 2021
Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical CystectomyVictor M Schuettfort, Benjamin Pradere, David D'Andrea, et al.
European Urology Oncology|May 16, 2024
Clofarabine Has a Superior Therapeutic Window as compared to Gemcitabine in Preclinical Bladder Cancer ModelsMichael Gutmann, Iris E Ertl, Paula Herek, et al.
The American Journal of Surgical Pathology|February 23, 2016
Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma SyndromeKiril Trpkov, Ondrej Hes, Abbas Agaimy, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
EGFR alterations and EML4-ALK rearrangement in primary adenocarcinoma of the urinary bladderRiley E Alexander, Rodolfo Montironi, Antonio Lopez-Beltran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2014
Next-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling genesGabriel G Malouf, Xiaoping Su, Hui Yao, et al.
European Urology Focus|June 10, 2025
A Systematic Review and Meta-analysis on Perioperative Stenting/Dwell Time and Postoperative Outcomes in Patients Undergoing Radical Cystectomy and Urinary Diversion for Bladder CancerMithun Kailavasan, Alberto Martini, Max Bruins, et al.
Pageof 25